Latest Breaking News On - Oasmia pharmaceutical - Page 10 : comparemela.com

TO: ALL PERSONS WHO PURCHASED OR OTHERWISE ACQUIRED OASMIA PHARMACEUTICAL AB ADSs FROM OCTOBER 23, 2015 THROUGH OCTOBER 14, 2019, BOTH DATES INCLUSIVE. YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Eastern District of New York, that a hearing will be held on May 19, 2021, at 11:00 a.m. before the Honorable Nicholas G. Garaufis, United States District Judge of the Eastern District of New York, United States Courthouse, Room 1426 S, 225 Cadman Plaza East, Brooklyn, NY 11201 for the purpose of determining: (1) whether the proposed settlement of the claims in the above-captioned Action ( Settlement ) for consideration including the sum of $2,350,000 ( Settlement Amount ) should be approved by the Court as fair, reasonable, and adequate; (2) whether the proposed plan to distribute the Settlement proceeds is fair, reasonable, and adequate; (3) whether the application of attorneys for Lead Plaintiffs ( Plaintiffs Counsel ) for an award of attor

New yorkUnited statesCadman plazaJeffg hammelNicholasg garaufisJonathan horneReed kathreinDanielle smithStrategic claims servicesUnited states district courtOrder of the united states district courtClerk of the courtAmerican depositary shares of oasmia pharmaceuticalsRosen law firmHagens berman sobol shapiroNet settlement fund